<DOC>
	<DOC>NCT00945997</DOC>
	<brief_summary>To compare the efficacy of two different dose regimens of misoprostol administered vaginally in combination with mifepristone in second trimester termination of (non)viable pregnancy.</brief_summary>
	<brief_title>Misoprostol for Second Trimester Termination of Pregnancy</brief_title>
	<detailed_description>The study was designed as a prospective double blinded randomised controlled trial, comparing 200µg to 400 µg misoprostol given vaginally at four hour intervals, starting 36-48 hours after the oral administration of mifepristone 200 mg at a gestational age between 14 to 24 weeks.</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Women with a gestational age between 14 to 24 weeks, confirmed by ultrasound, requesting termination of pregnancy No informed consent Mifepristone allergy Chronic adrenal gland failure Kidney failure Liver failure Chronic use of corticosteroids COPD not responsive to treatment Cardiovascular disease Glaucoma</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>misoprostol</keyword>
	<keyword>mifepristone</keyword>
	<keyword>medical abortion</keyword>
	<keyword>randomised controlled trial</keyword>
</DOC>